P. Wood

Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.

R. Campbell, F. Kamali, G. Ford, 1995, British heart journal.

Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans

F. Kamali, H. Wynne, P. Kesteven, 2001, American journal of hematology.

Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety

F. Kamali, A. Ward, P. Wood, 2009, Annals of Hematology.

Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design

M. Kilkenny, D. Cadilhac, B. Clissold, 2022, Neuroepidemiology.

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.

Peter Wood, F. Kamali, H. Wynne, 2005, Blood.

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

F. Kamali, H. Wynne, R. Frearson, 2004, Clinical pharmacology and therapeutics.

Dietary vitamin K influences intra‐individual variability in anticoagulant response to warfarin

F. Kamali, H. Wynne, C. Hankey, 2004, British journal of haematology.

Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin.

F. Kamali, H. Wynne, P. Avery, 2006, Thrombosis research.